Skip to main content
      After 3 years, 25% (95% CI: 13 to 38) remained flare-free in the tapering TNFi group compared to 85% (70 to 93) in the s

      Dr. Antoni Chan

      1 year ago
      After 3 years, 25% (95% CI: 13 to 38) remained flare-free in the tapering TNFi group compared to 85% (70 to 93) in the stable TNFi group, hazard ratio for flare of 9.4 (3.9 to 22.8), ARCTIC REWIND, Kjorholt K, LB Abst#L07 #ACR23 #ACRBest @RheumNow https://t.co/fqxfU3jE0q https://t.co/J0qBeKNsEW
      Palliative Care & Rheum - #ACR23 @RheumNow
      Consider Pall Care for Serious Illness: "high mortality risk & negati

      Eric Dein

      1 year ago
      Palliative Care & Rheum - #ACR23 @RheumNow Consider Pall Care for Serious Illness: "high mortality risk & negatively impacts function or QoL OR strains caregivers" - thats a lot of rheum pt @HopkinsBayview-led session, always pt-centric @kekuchinad @MymaAlbaydaMD @jhrheumatology https://t.co/1j4lrkb5Ra
      A memorable snap with the esteemed ACR rheumatologist, Dr. John Cush.
      #ACR23
      ⁦@RheumNow⁩ ⁦@ruby_taparia⁩ ⁦@Ama

      Sarath Chandra Mouli Veeravalli 🇮🇳

      1 year ago
      A memorable snap with the esteemed ACR rheumatologist, Dr. John Cush. #ACR23 ⁦@RheumNow⁩ ⁦@ruby_taparia⁩ ⁦@Amansharmapgi⁩ ⁦@eular_org⁩ @ InRheumatology @DandaDebashish @drdpshenoy @ DurgaPrasannaM1 @Amansharmapgi @ docrota @12VRavindran @abledoc https://t.co/jfIrMDq8ue
      In this Ph2b RCT of TAK-279 (TYK2i), pts w/ PsA given 15mg & 30mg achieved an ACR20 response at wk 12 vs. PBO(53.3%

      sheila

      1 year ago
      In this Ph2b RCT of TAK-279 (TYK2i), pts w/ PsA given 15mg & 30mg achieved an ACR20 response at wk 12 vs. PBO(53.3% and 54.2% vs 29.2%, both p = 0.002) ⬆️common TEAEs: Npharyngitis, URTI, headache & rash #ACR23 ABSL12 @RheumNow https://t.co/T6swJgw6vE
      Burden of flare & organ damage of SLE pts from the Asia Pacific cohort:
      Prevalence of organ damage at BL - 39%
      Incid

      sheila

      1 year ago
      Burden of flare & organ damage of SLE pts from the Asia Pacific cohort: Prevalence of organ damage at BL - 39% Incidence of damage accrual: ~58 per 1000PY Pts w/ >=2 flares accrued damage Flares independently⬆️risk of damage accrual #ACR23 ABST2261 @RheumNow @rheumarhyme https://t.co/nW34sI9FdP
      JAK1 TYK2 in RA
      Treatments in SpA